Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Neuropharmacology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.neuropharm.2016.03.024PMID 26995730
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Associations between intake of fish and n-3 long-chain polyunsaturated fatty acids and plasma metabolites related to the kynurenine pathway in patients with coronary artery disease

  2017cited by this paper
• Involvement of the kynurenine pathway in the pathogenesis of Parkinson's disease

  2017cited by this paper
• Cancer Immunotherapy by Targeting IDO1/TDO and Their Downstream Effectors

  2015cited by this paper
• Interferon Lambda Upregulates IDO1 Expression in Respiratory Epithelial Cells After Influenza Virus Infection

  2015cited by this paper
• Associations of Plasma Kynurenines With Risk of Acute Myocardial Infarction in Patients With Stable Angina Pectoris

  2015cited by this paper
• Kynurenic acid is a nutritional cue that enables behavioral plasticity.

  2015cited by this paper
• Expression of the Kynurenine Pathway in Human Peripheral Blood Mononuclear Cells: Implications for Inflammatory and Neurodegenerative Disease

  2015cited by this paper
• Kynurenine causes vasodilation and hypotension induced by activation of KCNQ-encoded voltage-dependent K(+) channels.

  2015cited by this paper
• Changing the Face of Kynurenines and Neurotoxicity: Therapeutic Considerations

  2015cited by this paper
• Indoleamine 2,3-Dioxygenase Fine-Tunes Immune Homeostasis in Atherosclerosis and Colitis through Repression of Interleukin-10 Production.

  2015cited by this paper
• Targeting the indoleamine 2,3-dioxygenase pathway in cancer

  2015cited by this paper
• Indoleamine 2,3-dioxygenase-1 is protective in atherosclerosis and its metabolites provide new opportunities for drug development

  2015cited by this paper
• Indoleamine 2,3 Dioxygenase (IDO) Expression and Activity in Relapsing- Remitting Multiple Sclerosis

  2015cited by this paper
• B regulatory cells are increased in hypercholesterolaemic mice and protect from lesion development via IL-10

  2015cited by this paper
• Protective Effect of Spermidine Against Excitotoxic Neuronal Death Induced by Quinolinic Acid in Rats: Possible Neurotransmitters and Neuroinflammatory Mechanism

  2015cited by this paper
• Inhibition of indoleamine 2,3-dioxygenase promotes vascular inflammation and increases atherosclerosis in Apoe-/- mice.

  2015cited by this paper
• Clinical Aspects of Huntington's Disease.

  2015cited by this paper
• Putative Neuroprotective and Neurotoxic Kynurenine Pathway Metabolites Are Associated with Hippocampal and Amygdalar Volumes in Subjects with Major Depressive Disorder

  2015cited by this paper
• [Nature Reviews Drug Discovery: editorial article of neuroscientists from Szeged about kynurenine (IF: 33.078)].

  2014cited by this paper
• Blockade of Indoleamine 2,3-Dioxygenase Reduces Mortality from Peritonitis and Sepsis in Mice by Regulating Functions of CD11b+ Peritoneal Cells

  2014cited by this paper
• The IDO Inhibitor Coptisine Ameliorates Cognitive Impairment in a Mouse Model of Alzheimer's Disease

  2014cited by this paper
• Quinolinic acid toxicity on oligodendroglial cells: relevance for multiple sclerosis and therapeutic strategies

  2014cited by this paper
• Indoleamine 2,3-Dioxygenase (IDO) Activity During the Primary Immune Response to Influenza Infection Modifies the Memory T Cell Response to Influenza Challenge

  2014cited by this paper
• Drug analog inhibition of indoleamine 2,3‐dioxygenase (IDO) activity modifies pattern recognition receptor expression and proinflammatory cytokine responses early during influenza virus infection

  2014cited by this paper
• Comparison of in vitro tests for antioxidant and immunomodulatory capacities of compounds.

  2014cited by this paper
• The kynurenine pathway of tryptophan catabolism, CD4+ T-cell recovery, and mortality among HIV-infected Ugandans initiating antiretroviral therapy.

  2014cited by this paper
• Mesenchymal stem cells use IDO to regulate immunity in tumor microenvironment.

  2014cited by this paper
• IDO2 in Immunomodulation and Autoimmune Disease

  2014cited by this paper
• Anti-Retroviral Therapy Decreases but Does Not Normalize Indoleamine 2,3-Dioxygenase Activity in HIV-Infected Patients

  2014cited by this paper
• Tumor necrosis factor α is associated with viral control and early disease progression in patients with HIV type 1 infection.

  2014cited by this paper
• Urinary excretion of kynurenine and tryptophan, cardiovascular events, and mortality after elective coronary angiography.

  2013cited by this paper
• of amyotrophic lateral sclerosis

  2013cited by this paper
• Distinct Tryptophan Catabolism and Th17/Treg Balance in HIV Progressors and Elite Controllers

  2013cited by this paper
• Characterization and Comparative Profiling of MicroRNAs in a Sexual Dimorphism Insect, Eupolyphaga sinensis Walker

  2013cited by this paper
• Expression of Tryptophan 2,3-Dioxygenase and Production of Kynurenine Pathway Metabolites in Triple Transgenic Mice and Human Alzheimer's Disease Brain

  2013cited by this paper
• Increased 3-Hydroxykynurenine serum concentrations differentiate Alzheimer’s disease patients from controls

  2013cited by this paper
• The Kynurenine Pathway in Stem Cell Biology

  2013cited by this paper
• Inhibition of indoleamine 2,3-dioxygenase enhances the T-cell response to influenza virus infection.

  2013cited by this paper
• Cardiovascular disease in Europe 2014: epidemiological update.

  2013cited by this paper
• Post-ischemic treatment with L-kynurenine sulfate exacerbates neuronal damage after transient middle cerebral artery occlusion.

  2013cited by this paper
• Mitochondrial disturbances, excitotoxicity, neuroinflammation and kynurenines: novel therapeutic strategies for neurodegenerative disorders.

  2012cited by this paper
• The kynurenine pathway and quinolinic acid: pivotal roles in HIV associated neurocognitive disorders

  2012cited by this paper
• Kynurenines in the CNS: recent advances and new questions

  2012cited by this paper
• The role of kynurenines in the pathomechanism of amyotrophic lateral sclerosis and multiple sclerosis: therapeutic implications

  2012cited by this paper
• Will the real multiple sclerosis please stand up?

  2012cited by this paper
• The kynurenine system and immunoregulation

  2012cited by this paper
• Will the real multiple sclerosis please stand up?

  2012cited by this paper
• Quinolinic acid, the inescapable neurotoxin

  2012cited by this paper
• The tryptophan metabolite 3-hydroxyanthranilic acid lowers plasma lipids and decreases atherosclerosis in hypercholesterolaemic mice.

  2012cited by this paper
• The kynurenine pathway in neurodegenerative diseases: mechanistic and therapeutic considerations.

  2012cited by this paper
• Inhibition of Indoleamine 2,3-Dioxygenase Activity by Levo-1-Methyl Tryptophan Blocks Gamma Interferon-Induced Chlamydia trachomatis Persistence in Human Epithelial Cells

  2011cited by this paper
• Aging-associated increase in indoleamine 2,3-dioxygenase (IDO) activity appears to be unrelated to the transcription of the IDO1 or IDO2 genes in peripheral blood mononuclear cells

  2011cited by this paper
• Kynurenine 3-monooxygenase inhibition in blood ameliorates neurodegeneration.

  2011cited by this paper
• Interferon-γ Regulates the Proliferation and Differentiation of Mesenchymal Stem Cells via Activation of Indoleamine 2,3 Dioxygenase (IDO)

  2011cited by this paper
• Endogenous neuroprotection in chronic neurodegenerative disorders: with particular regard to the kynurenines

  2011cited by this paper
• Huntington's disease: from molecular pathogenesis to clinical treatment

  2011cited by this paper
• The kynurenine pathway modulates neurodegeneration in a Drosophila model of Huntington's disease.

  2011cited by this paper
• Systemic Markers of Interferon-&ggr;–Mediated Immune Activation and Long-Term Prognosis in Patients With Stable Coronary Artery Disease

  2011cited by this paper
• Characterization of the kynurenine pathway in NSC‐34 cell line: implications for amyotrophic lateral sclerosis

  2011cited by this paper
• Neuroprotective effects of a novel kynurenic acid analogue in a transgenic mouse model of Huntington’s disease

  2011cited by this paper
• Dendritic Cells, Indoleamine 2,3 Dioxygenase and Acquired Immune Privilege

  2010cited by this paper
• Activation of indoleamine 2,3-dioxygenase-induced tryptophan degradation in advanced atherosclerotic plaques: Tampere Vascular Study

  2010cited by this paper
• Tryptophan Catabolism by Indoleamine 2,3-Dioxygenase 1 Alters the Balance of TH17 to Regulatory T Cells in HIV Disease

  2010cited by this paper
• The Fat-Fed Apolipoprotein E Knockout Mouse Brachiocephalic Artery in the Study of Atherosclerotic Plaque Rupture

  2010cited by this paper
• Tryptophan, Neurodegeneration and HIV-Associated Neurocognitive Disorder

  2010cited by this paper
• Understanding the Roles of the Kynurenine Pathway in Multiple Sclerosis Progression

  2010cited by this paper
• Protective effect of systemic L-kynurenine and probenecid administration on behavioural and morphological alterations induced by toxic soluble amyloid beta (25-35) in rat hippocampus.

  2010cited by this paper
• Kynurenine is an endothelium-derived relaxing factor produced during inflammation

  2010cited by this paper
• Indoleamine 2,3-dioxygenase and 3-hydroxykynurenine modifications are found in the neuropathology of Alzheimer's disease

  2010cited by this paper
• Dysfunctional kynurenine pathway metabolism in the R6/2 mouse model of Huntington’s disease

  2010cited by this paper
• Of mice, rats and men: Revisiting the quinolinic acid hypothesis of Huntington's disease.

  2010cited by this paper
• Interferon-gamma-inducible kynurenines/pteridines inflammation cascade: implications for aging and aging-associated psychiatric and medical disorders

  2010cited by this paper
• Tranilast suppresses prostate cancer growth and osteoclast differentiation in vivo and in vitro

  2010cited by this paper
• The Kynurenine Pathway and Inflammation in Amyotrophic Lateral Sclerosis

  2010cited by this paper
• Acute intrastriatal administration of quinolinic acid provokes hyperphosphorylation of cytoskeletal intermediate filament proteins in astrocytes and neurons of rats.

  2010cited by this paper
• Characterisation of the Expression of NMDA Receptors in Human Astrocytes

  2010cited by this paper
• Recent advances in the treatment of amyotrophic lateral sclerosis. Emphasis on kynurenine pathway inhibitors.

  2009cited by this paper
• Kynurenine Pathway Metabolites in Humans: Disease and Healthy States

  2009cited by this paper
• Kynurenines in chronic neurodegenerative disorders: future therapeutic strategies

  2009cited by this paper
• The Excitotoxin Quinolinic Acid Induces Tau Phosphorylation in Human Neurons

  2009cited by this paper
• Kynurenine pathway inhibition reduces central nervous system inflammation in a model of human African trypanosomiasis

  2009cited by this paper
• Mechanism for Quinolinic Acid Cytotoxicity in Human Astrocytes and Neurons

  2009cited by this paper
• Combined Effect of Antiretroviral Therapy and Blockade of IDO in SIV-Infected Rhesus Macaques1

  2009cited by this paper
• L-kynurenine: Metabolism and mechanism of neuroprotection

  2008cited by this paper
• ORIGINAL ARTICLE Indoleamine 2,3-dioxygenase activity associates with cardiovascular risk factors: The Health 2000 study

  2008cited by this paper
• Prolonged kynurenine 3-hydroxylase inhibition reduces development of levodopa-induced dyskinesias in parkinsonian monkeys.

  2008cited by this paper
• Toxicology and pharmacokinetics of 1-methyl-d-tryptophan: absence of toxicity due to saturating absorption.

  2008cited by this paper
• Kynurenine pathway metabolism in human blood–brain–barrier cells: implications for immune tolerance & neurotoxicity

  2008cited by this paper
• Creating immune privilege: active local suppression that benefits friends, but protects foes

  2008cited by this paper
• Timeliness of diagnosis in Motor Neurone Disease: a population-based study

  2008cited by this paper
• Indoleamine 2,3‐dioxygenase enzyme activity correlates with risk factors for atherosclerosis: the Cardiovascular Risk in Young Finns Study

  2007cited by this paper
• Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.

  2007cited by this paper
• Characterization of the Kynurenine Pathway in Human Neurons

  2007cited by this paper
• The Countervailing Actions of Myeloid and Plasmacytoid Dendritic Cells Control Autoimmune Diabetes in the Nonobese Diabetic Mouse1

  2007cited by this paper
• Denervation-induced skeletal muscle atrophy is associated with increased mitochondrial ROS production.

  2007cited by this paper
• IDO expression in the brain: a double-edged sword

  2007cited by this paper
• Riluzole and amyotrophic lateral sclerosis survival: a population‐based study in southern Italy

  2007cited by this paper
• The anti-allergic drug, N-(3',4'-dimethoxycinnamonyl) anthranilic acid, exhibits potent anti-inflammatory and analgesic properties in arthritis.

  2007cited by this paper
• Characterization of an indoleamine 2,3-dioxygenase-like protein found in humans and mice.

  2007cited by this paper
• In vitro evidence for an antioxidant role of 3-hydroxykynurenine and 3-hydroxyanthranilic acid in the brain.

  2007cited by this paper

• IDO family: the metabolic crossroads connecting immunity, nerves and tumors

  2026cites this paper
• Metabolic Alterations Induced by a Seizure-Causing Sodium Channel Mutation and their Partial Normalization by Dietary α-Linolenic Acid in Drosophila

  2026cites this paper
• Metabolic profiling in major depressive disorder with high psychological resilience: changes in amino acid and carbohydrate metabolism

  2026cites this paper
• Combined treatment with naringin and osthole ameliorates colitis through microbiota–amino acid metabolism and the JNK pathway

  2026cites this paper
• Kynurenine: A Promising Structural Motif for Diverse Biological Active Peptides.

  2026cites this paper
• Targeting IDO1 in Huntington’s Disease: Network Pharmacology and Preclinical Evidence from Coffea arabica

  2025cites this paper
• Decoding microglial immunometabolism: a new frontier in Alzheimer's disease research

  2025cites this paper
• Tryptophan Metabolism in Health and Disease- Implications for non-communicable diseases.

  2025cites this paper
• Neuroprotective effect of the herbal pair Coptidis Rhizoma-Cinnamomi Cortex against 6-OHDA-induced Parkinson's disease rats through promotion of autophagy via the PI3K/AKT/mTOR pathway.

  2025cites this paper
• Tryptophan metabolism and ischemic stroke: An intricate balance

  2025cites this paper
• Biological properties of vitamins of the B-complex, part 2 - vitamins B6 and B7 (biotin, vitamin H).

  2025cites this paper
• Kynurenine Pathway Dysregulation in Parkinson’s Disease: Insights for Disease Modulation and Therapy

  2025cites this paper
• Kynurenine Pathway in Epilepsy: Unraveling Its Role in Glutamate Excitotoxicity, GABAergic Dysregulation, Neuroinflammation, and Mitochondrial Dysfunction

  2025cites this paper
• Escitalopram alters tryptophan metabolism, plasma lipopolysaccharide, and the inferred functional potential of the gut microbiome in deer mice showing compulsive-like rigidity

  2025cites this paper
• An untargeted metabolome-wide association study of maternal perinatal tobacco smoking in newborn blood spots

  2025cites this paper
• Chaihu-Jia-Longgu-Muli Decoction Improves Dizziness with Anxiety in Rats by Modulating Tryptophan Metabolism.

  2025cites this paper
• Renal and hepatic function is preserved following inducible knockout of kynurenine pathway enzymes KMO or QPRT in adult mice

  2025cites this paper
• Kynurenine pathway in Parkinson’s disease: pathophysiological roles and therapeutic interventions

  2025cites this paper
• Metabolomics of the Kynurenine Pathway by Laser Desorption Ionization Mass Spectrometry (LDI-MS).

  2025cites this paper
• Indolo-quinazoline in Medicinal Chemistry as an Anticancer Agents: Current Trends and Future Opportunities

  2025cites this paper
• Serum Metabolomic Profiling in Possible Early-Stage Multiple Sclerosis: A Targeted 1H-NMR Comparison of OCB Type 1 and Type 2 Patterns

  2025cites this paper
• Advancing our understanding of schizophrenia: insights from recent research, emerging therapies, and future directions

  2025cites this paper
• Tryptophan Metabolism Through the Kynurenine Pathway in Glial Cells

  2025cites this paper
• Kynurenines and Mitochondrial Disturbances in Multiple Sclerosis

  2025cites this paper
• Exploring novel non-opioid pathways and therapeutics for pain modulation

  2025cites this paper
• Quinoline Quest: Kynurenic Acid Strategies for Next-Generation Therapeutics via Rational Drug Design

  2025influential citation
• Aetiopathogenesis of infantile epileptic spasms syndrome and mechanisms of action of adrenocorticotrophin hormone/corticosteroids in children: A scoping review

  2025cites this paper
• Decoupling Behavioral Domains via Kynurenic Acid Analog Optimization: Implications for Schizophrenia and Parkinson’s Disease Therapeutics

  2025cites this paper
• De novo NAD+ synthesis is ineffective for NAD+ supply in axenically cultured Caenorhabditis elegans

  2025cites this paper
• Research progress and perspectives of dual-target inhibitors.

  2025cites this paper
• Temporal metabolic reprogramming in DSS-induced colitis identifies purine metabolism and trigonelline as novel therapeutic targets

  2025cites this paper
• Effects of a Gain-of-Function Mutation in the Voltage-Gated Sodium Channel Gene, and of Dietary α-Linolenic Acid Supplementation, on Whole-Body Metabolism in Drosophila

  2025cites this paper
• Picolinic acid, a tryptophan metabolite, exhibits anabolic effects in muscle cells and improves lifespan and movement in C. elegans

  2025cites this paper
• Predictive value of kynurenine pathway metabolites in the severity of patients with obsessive‐compulsive disorder

  2025cites this paper
• Behavioral Balance in Tryptophan Turmoil: Regional Metabolic Rewiring in Kynurenine Aminotransferase II Knockout Mice

  2025cites this paper
• Oxidative Stress-Related Metabolomic Alterations in Pregnancy: Evidence from Exposure to Air Pollution, Metals/Metalloid, and Tobacco Smoke

  2025cites this paper
• Targeted LC-MS/MS metabolomics reveals distinctive tryptophan pathway signatures in pneumocystis jirovecii pneumonia.

  2025cites this paper
• Agathisflavone Modulates the Kynurenine Pathway and Glial Inflammatory Responses with Implications for Neuroprotection

  2025cites this paper
• Gut Microbiome, Diet and Depression: Literature Review of Microbiological, Nutritional and Neuroscientific Aspects

  2025cites this paper
• Diverse Physiological Roles of Kynurenine Pathway Metabolites: Updated Implications for Health and Disease

  2025cites this paper
• Special Issue “Molecular Mechanisms of Neurological and Psychiatric Disease: A Decade of Progress”

  2025cites this paper
• Beyond tumour suppression: cGAS‐STING pathway in urologic malignancies: Context‐dependent duality and therapeutic implications

  2025cites this paper
• Tryptophan‐sensing receptor GPR142 expression levels are directly regulated by proinflammatory cytokines in ghrelin‐producing cells

  2025cites this paper
• Kynurenine Pathway Modulation by Exercise in Multiple Sclerosis: Implications for Neuroprotection and Inflammation

  2025cites this paper
• Inhibition of Indoleamine 2,3-Dioxygenase Exerts Antidepressant-like Effects through Distinct Pathways in Prelimbic and Infralimbic Cortices in Rats under Intracerebroventricular Injection with Streptozotocin

  2024cites this paper
• Research Progress of Tryptophan and Its Metabolites in the Microbial-Gut-Brain Axis

  2024cites this paper
• Effects of exposure to trihalomethanes in swimming pool waters on metabolomics profile: a randomized parallel design trial

  2024cites this paper
• Development and Optimization of a Target Engagement Model of Brain IDO Inhibition for Alzheimer's Disease.

  2024cites this paper
• The tryptophan metabolic pathway of the microbiome and host cells in health and disease

  2024cites this paper
• A microfluidic-based gut-on-a-chip model containing the gut microbiota of patients with depression reveals physiological characteristics similar to depression.

  2024cites this paper
• Staunch the Age Related Decline into Dementia, Cancer, Autoimmunity (Long Covid), Obesity, and Other Diseases with a Prebiotic, Probiotic, Postbiotic Triple Play

  2024cites this paper
• Kynurenines and Inflammation: A Remarkable Axis for Multiple Sclerosis Treatment

  2024cites this paper
• Visualization of incrementally learned projection trajectories for longitudinal data

  2024cites this paper
• Biocatalytic Reactions, Crystal Structures and Mechanisms of Kynurenine Formamidases

  2024cites this paper
• A Review of the Evidence for Tryptophan and the Kynurenine Pathway as a Regulator of Stem Cell Niches in Health and Disease

  2024influential citation
• Modifying carbon dots with L-phenylalanine for rapid discrimination of tryptophan enantiomers.

  2024cites this paper
• VEEV TC-83 Triggers Dysregulation of the Tryptophan–Kynurenine Pathway in the Central Nervous System That Correlates with Cognitive Impairment in Tg2576 Mice

  2024cites this paper
• Kynurenin: Stoffwechselprodukt mit Potenzial

  2024cites this paper
• Identifying plasma metabolic characteristics of major depressive disorder, bipolar disorder, and schizophrenia in adolescents

  2024cites this paper
• A Novel RP-UHPLC-MS/MS Approach for the Determination of Tryptophan Metabolites Derivatized with 2-Bromo-4′-Nitroacetophenone

  2024cites this paper
• Double-duty isomerases: a case study of isomerization-coupled enzymatic catalysis.

  2024cites this paper
• A pilot investigation of the association between HIV-1 Vpr amino acid sequence diversity and the tryptophan-kynurenine pathway as a potential mechanism for neurocognitive impairment

  2024influential citation
• Dulaglutide treatment reverses depression‐like behavior and hippocampal metabolomic homeostasis in mice exposed to chronic mild stress

  2024cites this paper
• The Impact of C-3 Side Chain Modifications on Kynurenic Acid: A Behavioral Analysis of Its Analogs in the Motor Domain

  2024cites this paper
• Neuroprotection effects of kynurenic acid-loaded micelles for the Parkinson’s disease models

  2024cites this paper
• The possible interaction between tryptophan and its metabolites with delirium in older patients with critical illnesses

  2024cites this paper
• Harnessing Melatonergic Agonists and Antagonists: A Dual Approach to Alleviating Depression and Depression-associated Insomnia

  2024cites this paper
• Streamlined Flow Synthesis of Plasmonic Nanoparticles and SERS Detection of Uremic Toxins with Trace-Level Liquid Volumes in a Microchamber.

  2024cites this paper
• Baseline Inflammation but not Exercise Modality Impacts Exercise-induced Kynurenine Pathway Modulation in Persons With Multiple Sclerosis: Secondary Results From a Randomized Controlled Trial

  2024cites this paper
• Perfluorooctane sulfonate (PFOS) and benzo[a]pyrene (BaP) synergistically induce neurotoxicity in C6 rat glioma cells via the activation of neurotransmitter and Cyp1a1-mediated steroid hormone synthesis pathways.

  2024cites this paper
• Gut-brain axis and neurodegeneration: mechanisms and therapeutic potentials

  2024cites this paper
• Intestinal endogenous metabolites affect neuroinflammation in 5×FAD mice by mediating “gut-brain” axis and the intervention with Chinese Medicine

  2024cites this paper
• Ido2 Deficiency Exacerbates Motor Impairment and Reduces Aryl Hydrocarbon Receptor Activity through Decreased Kynurenine in a Chronic Demyelinating Mouse Model

  2024cites this paper
• The Biology and Biochemistry of Kynurenic Acid, a Potential Nutraceutical with Multiple Biological Effects

  2024cites this paper
• Molecular mechanisms and therapeutic significance of Tryptophan Metabolism and signaling in cancer

  2024cites this paper
• Serum neurotransmitter analysis of motor and non-motor symptoms in Parkinson’s patients

  2024cites this paper
• Modulation of Aromatic Amino Acid Metabolism by Indigenous Non-Saccharomyces Yeasts in Croatian Maraština Wines

  2024cites this paper
• Tryptophan metabolism determines outcome in tuberculous meningitis: a targeted metabolomic analysis

  2023influential citation
• Wuzang Wenyang Huayu Tang Promoting Learning-memory Ability in Vascular Dementia Rats via Brain-gut-microbiome Axis

  2023cites this paper
• CSF neopterin, quinolinic acid and kynurenine/tryptophan ratio are biomarkers of active neuroinflammation

  2023cites this paper
• Modulation of T cells by tryptophan metabolites in the kynurenine pathway.

  2023cites this paper
• The kynurenine pathway in major depressive disorder, bipolar disorder, and schizophrenia: a systematic review and meta-analysis of cerebrospinal fluid studies

  2023cites this paper
• Metabolomic Footprint of Disrupted Energetics and Amino Acid Metabolism in Neurodegenerative Diseases: Perspectives for Early Diagnosis and Monitoring of Therapy

  2023cites this paper
• Therapeutic potential of targeting kynurenine pathway in neurodegenerative diseases.

  2023cites this paper
• The kynurenine pathway relates to post‐acute COVID‐19 objective cognitive impairment and PASC

  2023influential citation
• Aryl hydrocarbon receptor dependent anti-inflammation and neuroprotective effects of tryptophan metabolites on retinal ischemia/reperfusion injury

  2023cites this paper
• Activation of aryl hydrocarbon receptor (AhR) in Alzheimer’s disease: role of tryptophan metabolites generated by gut host-microbiota

  2023cites this paper
• Kynurenine pathway metabolites modulated the comorbidity of IBD and depressive symptoms through the immune response.

  2023cites this paper
• Effects of Ozone on Sickness and Depressive-like Behavioral and Biochemical Phenotypes and Their Regulation by Serum Amyloid A in Mice

  2023influential citation
• Tryptophan metabolism determines outcome in tuberculous meningitis: a targeted metabolomic analysis

  2023cites this paper
• Phase-and disorder-specific differences in peripheral metabolites of the kynurenine pathway in major depression, bipolar affective disorder and schizophrenia

  2023cites this paper
• PTSD, Immune System, and Inflammation.

  2023cites this paper
• Decreased kynurenine in cerebrospinal fluid and potential role in neuromyelitis optica spectrum disorder

  2023cites this paper
• Tryptophan Metabolism in Central Nervous System Diseases: Pathophysiology and Potential Therapeutic Strategies

  2023cites this paper
• Tryptophan metabolism as a ‘reflex’ feature of neuroimmune communication: Sensor and effector functions for the indoleamine‐2, 3‐dioxygenase kynurenine pathway

  2023cites this paper
• Disposable Molecularly Imprinted Polymer-Modified Screen-Printed Electrodes for Rapid Electrochemical Detection of l-Kynurenine in Human Urine

  2023cites this paper
• First trimester human umbilical cord perivascular cells (HUCPVC) modulate the kynurenine pathway and glutamate neurotransmission in an LPS-induced mouse model of neuroinflammation

  2023cites this paper
• COVID-19. Biology, pathophysiology, and immunology: a pathologist view

  2023cites this paper
• Corrigendum: Research progress on microRNA-1258 in the development of human cancer

  2023cites this paper
• Tryptophan metabolism-related gene expression patterns: unveiling prognostic insights and immune landscapes in uveal melanoma

  2023cites this paper